These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 2521900

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ, Albers LJ, Le H, Creese I.
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The role of dopaminergic systems in opioid receptor desensitization in nucleus accumbens and caudate putamen of rat after chronic morphine treatment.
    Noble F, Cox BM.
    J Pharmacol Exp Ther; 1997 Nov; 283(2):557-65. PubMed ID: 9353370
    [Abstract] [Full Text] [Related]

  • 7. Role of calmodulin-dependent phosphorylation in chronic sulpiride-induced striatal dopamine receptor supersensitivity.
    Lau YS, Runice C, Dowd F.
    J Pharmacol Exp Ther; 1984 Apr; 229(1):32-7. PubMed ID: 6323689
    [Abstract] [Full Text] [Related]

  • 8. Repeated amphetamine administration alters the interaction between D1-stimulated adenylyl cyclase activity and calmodulin in rat striatum.
    Roseboom PH, Hewlett GH, Gnegy ME.
    J Pharmacol Exp Ther; 1990 Oct; 255(1):197-203. PubMed ID: 2145422
    [Abstract] [Full Text] [Related]

  • 9. Agonist-induced desensitization of D1-dopamine receptors linked to adenylyl cyclase activity in cultured NS20Y neuroblastoma cells.
    Barton AC, Sibley DR.
    Mol Pharmacol; 1990 Oct; 38(4):531-41. PubMed ID: 1978240
    [Abstract] [Full Text] [Related]

  • 10. Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain.
    Undie AS, Friedman E.
    J Pharmacol Exp Ther; 1990 Jun; 253(3):987-92. PubMed ID: 1972756
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Desensitization of rat striatal dopamine-stimulated adenylate cyclase after acute amphetamine administration.
    Barnett JV, Kuczenski R.
    J Pharmacol Exp Ther; 1986 Jun; 237(3):820-5. PubMed ID: 2940359
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH, Kline RH, Geter-Douglass B, Izenwasser S, Witkin JM, Newman AH.
    J Med Chem; 1996 Aug 16; 39(17):3423-8. PubMed ID: 8765528
    [Abstract] [Full Text] [Related]

  • 19. Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems.
    Sonsalla PK, Gibb JW, Hanson GR.
    J Pharmacol Exp Ther; 1986 Sep 16; 238(3):932-7. PubMed ID: 2943891
    [Abstract] [Full Text] [Related]

  • 20. Dopamine receptor changes in response to prolonged treatment with L-dopa.
    Groppetti A, Flauto C, Parati E, Vescovi A, Rusconi L, Parenti M.
    J Neural Transm Suppl; 1986 Sep 16; 22():33-45. PubMed ID: 2946813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.